Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...

Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

The Food and Drug Administration on Wednesday approved a powerful new drug that provides almost complete protection against HIV infections. The twice-yearly injection, known as lenacapavir, offers ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

The US HIV/AIDS Strategy and Ending the HIV Epidemic (EHE) initiatives aim to reduce HIV transmission by 90% by 2030 through targeted care and prevention initiatives such as the Undetectable = ...

The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...